Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novacare (NOV) breaking out... -- Ignore unavailable to you. Want to Upgrade?

To: Sigmund who wrote (264)	4/2/1998 7:00:00 PM
From: rich eng	Respond to of 420

peo buisness is just going to explode in the next several years i think the risk with nces or any other peo lies in the margin of profit. NCES 2.1 million on 569.5 million revenue is nowhere near the % profit margin of rehab which will also continue to grow. Having said that i feel that nces will rapidly improve both revenue and profit margin and would buy both stocks. I am currently kicking myself for not buying NCES a month ago.

To: Sigmund who wrote (264)	4/5/1998 7:45:00 PM
From: JB Cocallas	Respond to of 420

Hey Sig, On a percentage basis you would do better with NCES On safety NOV is better Nov owns 70% or so of NCES so I think the risk is small. NCES has a smaller float so the price movements can be great on a small amount of volume.. note the 1 minute chart of last friday. NCES went from 8.5 to 7.5 or so on little volume so buy the dips and don't chase it... NCES is on the acquisition trail for small regional peo businesses so their earnings will take a while to grow as they roll new businesses into their operations. Read the edgar filings for details